Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Wnt/β-catenin

Items 21-30 of 40

Page
per page
  1. CCT251545
    B5979 CCT251545
    Summary: Orally bioavailable and potent WNT signaling inhibitor
      ≥42.2 mg/mL
  2. Wnt agonist 1
    B6059 Wnt agonist 1
     1 Citation
    Summary: agonist of Wnt signaling pathway
      ≥38.7 mg/mL
  3. IWP-3
    C3254 IWP-3
    Summary: inhibitor of Wnt production
      ≤0.1 mg/mL
  4. IWP-2-V2
    C3625 IWP-2-V2
    Summary: Wnt production inhibitor
      ≤2 mg/mL
  5. HLY78
    C5433 HLY78
    Summary: positive modulator of the Wnt/β-catenin pathway
      ≤2 mg/mL
  6. IWR-1-endo
    B2306 IWR-1-endo
     1 Citation
    Summary: Potent Wnt signaling inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.45 mg/mL
  7. iCRT 14
    B4687 iCRT 14
    Summary: CRT inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.75 mg/mL
  8. QS 11
    B7364 QS 11
    Summary: ARFGAP1 inhibitor,Wnt/beta-catenin pathway modulator
      Soluble in DMSO
  9. PNU 74654
    B7422 PNU 74654
    Summary: Wnt signaling pathway inhibitor
      insoluble in H2O; insoluble in EtOH; ≥24.8 mg/mL
  10. Neurodazine
    B7457 Neurodazine
    Summary: Induces neurogenesis of non-pluripotent C2C12 myoblasts
      Soluble in DMSO

Items 21-30 of 40

Page
per page